A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A pharmacogenetic intervention for the improvement of the safety profile of antipsychotic treatments
Authors
Keywords
-
Journal
Translational Psychiatry
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-25
DOI
10.1038/s41398-019-0511-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication
- (2018) Lucas M. Walden et al. PSYCHIATRY RESEARCH
- Does Pharmacogenomic Testing Improve Clinical Outcomes for Major Depressive Disorder?
- (2017) Joshua D. Rosenblat et al. JOURNAL OF CLINICAL PSYCHIATRY
- Systematic evaluation of commercial pharmacogenetic testing in psychiatry
- (2017) Chad A. Bousman et al. Pharmacogenetics and Genomics
- Pharmacogenetic testing for the guidance of psychiatric treatment: a multicenter retrospective analysis
- (2016) Jordi Espadaler et al. CNS SPECTRUMS
- Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response
- (2016) Chiara Fabbri et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Pharmacogenetic Prediction of Individual Variability in Drug Response Based on CYP2D6, CYP2C9 and CYP2C19 Genetic Polymorphisms
- (2015) Shafqat Chaudhry et al. CURRENT DRUG METABOLISM
- Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation
- (2015) Joel G. Winner et al. CURRENT MEDICAL RESEARCH AND OPINION
- Physicians' opinions following pharmacogenetic testing for psychotropic medication
- (2015) Lucas M. Walden et al. PSYCHIATRY RESEARCH
- What is needed to incorporate clinical pharmacogenetic tests into the practice of psychopharmacotherapy?
- (2015) Jose de Leon et al. Expert Review of Clinical Pharmacology
- The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy
- (2015) D. Brixner et al. JOURNAL OF MEDICAL ECONOMICS
- Improved Antidepressant Remission in Major Depression via a Pharmacokinetic Pathway Polygene Pharmacogenetic Report
- (2015) Ajeet B. Singh Clinical Psychopharmacology and Neuroscience
- Positive perception of pharmacogenetic testing for psychotropic medications
- (2014) Matthew B. Lanktree et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Does Pharmacogenetic Testing for CYP450 2D6 and 2C19 Among Patients with Diagnoses within the Schizophrenic Spectrum Reduce Treatment Costs?
- (2013) Louise Herbild et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- CYP450 Pharmacogenetic treatment strategies for antipsychotics: A review of the evidence
- (2013) Dana Ravyn et al. SCHIZOPHRENIA RESEARCH
- Using a pharmacogenomic algorithm to guide the treatment of depression
- (2012) D K Hall-Flavin et al. Translational Psychiatry
- High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases
- (2009) A L Zackrisson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
- (2008) Ulrich M. Zanger et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started